229 related articles for article (PubMed ID: 27627984)
1. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors.
Romanucci M; Massimini M; Ciccarelli A; Malatesta D; Bongiovanni L; Gasbarre A; Della Salda L
Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984
[TBL] [Abstract][Full Text] [Related]
2. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
4. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
[TBL] [Abstract][Full Text] [Related]
5. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
Preziosi R; Morini M; Sarli G
J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
[TBL] [Abstract][Full Text] [Related]
6. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
[TBL] [Abstract][Full Text] [Related]
7. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
[TBL] [Abstract][Full Text] [Related]
8. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
[TBL] [Abstract][Full Text] [Related]
9. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
[TBL] [Abstract][Full Text] [Related]
10. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
[TBL] [Abstract][Full Text] [Related]
11. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
Meyer A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
[TBL] [Abstract][Full Text] [Related]
12. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
Meyer A; Gruber AD; Klopfleisch R
Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
[TBL] [Abstract][Full Text] [Related]
13. Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.
Hämäläinen S; Kareinen L; Sukura A; Kareinen I
Vet Pathol; 2022 Mar; 59(2):236-243. PubMed ID: 34894899
[TBL] [Abstract][Full Text] [Related]
14. The phosphoinositide 3-kinase pathway is crucial for the growth of canine mast cell tumors.
Amagai Y; Tanaka A; Matsuda A; Oida K; Jung K; Matsuda H
J Vet Med Sci; 2013; 75(6):791-4. PubMed ID: 23328607
[TBL] [Abstract][Full Text] [Related]
15. Canine mast cell tumors express stem cell factor receptor.
Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
[TBL] [Abstract][Full Text] [Related]
16. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
18. VEGF expression in dog mastocytoma.
Mederle O; Mederle N; Bocan EV; Ceauşu R; Raica M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):185-8. PubMed ID: 20509299
[TBL] [Abstract][Full Text] [Related]
19. Nanog Expression and Proliferation Indices in Canine Cutaneous Mast Cell Tumors.
Joselevitch JA; Barra CN; Vargas THM; Pulz LH; Nishiya AT; Kleeb SR; Xavier JG; Catão-Dias JL; Strefezzi RF
Vet Pathol; 2018 Nov; 55(6):849-852. PubMed ID: 30025495
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive significance of KIT protein expression and c-kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology Working Group.
Thamm DH; Avery AC; Berlato D; Bulman-Fleming J; Clifford CA; Hershey AE; Intile JL; Jones PD; Kamstock DA; Liptak JM; Pavuk A; Peauroi J; Powell R; Rissetto K; Valli VEO; Webster JD
Vet Comp Oncol; 2019 Dec; 17(4):451-455. PubMed ID: 31264352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
